Delivery Order SPE2DB20D3103-SPE2DB23FP0X4
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Telmisartan 40 mg tablets. The contract, valued at $31,017.60, is a firm fixed-price delivery order with a completion date of September 1, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $1,468.08 firm fixed-price delivery order is for the supply of Telmisartan 40 mg tablets. The contract has an ultimate completion date of September 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Telmisartan 40 mg tablets. The firm-fixed-price contract, valued at $1,103.80, has a completion date of January 23, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive...
- This federal contract award, valued at $1,363.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Telmisartan 40 mg tablets to support military and government healthcare programs. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of November 17, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,441.72, is for the delivery of Telmisartan 40 mg tablets to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. This...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of Telmisartan 40 mg tablets in 30-count packages, with a ceiling value of $2,287.16 and a period of performance through June 12, 2025. This contract is not designated as a set-aside and is an open competition. Amerisourcebergen Drug...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Telmisartan 40 mg tablets. The award, valued at $1,293.60, is a Firm Fixed Price delivery order contract that will run through February 4, 2025. This contract appears to be a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
- This federal contract award, valued at $2,589.79, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 40 mg tablets, a cardiovascular medication, to support military and government healthcare programs. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,563,045,338 units of the pharmaceutical product Telmisartan 40 mg tablets. The $1,780.90 delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). The contract has an ultimate completion date of December 11, 2023 and utilizes a firm fixed price pricing type. Amerisourcebergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $8,322.00, is for the delivery of Telmisartan 40 mg tablets in 30-count packages. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 25, 2023. The contract has no set-aside designation, indicating it was awarded through full and open competition....
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FP0X4Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company and subsidiary of Cencora, Inc. The contract, valued at $2,239.90, is for the delivery of Telmisartan 40 mg tablets to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities worldwide. This award is likely a delivery order under that broader IDC.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 7/24/23 |